|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 186 out of 186 for Apoc1

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.055s

Categories

Category: Publication
Type Details Score
Publication
First Author: van Keulen D
Year: 2018
Journal: PLoS One
Title: Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice.
Volume: 13
Issue: 10
Pages: e0204911
Publication
First Author: de Jong RCM
Year: 2018
Journal: Sci Rep
Title: Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response.
Volume: 8
Issue: 1
Pages: 6753
Publication
First Author: Liang W
Year: 2013
Journal: PLoS One
Title: Coordinated and interactive expression of genes of lipid metabolism and inflammation in adipose tissue and liver during metabolic overload.
Volume: 8
Issue: 9
Pages: e75290
Publication
First Author: van Vlijmen BJ
Year: 1996
Journal: J Clin Invest
Title: Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
Volume: 97
Issue: 5
Pages: 1184-92
Publication
First Author: Chapman S
Year: 2000
Journal: Neuroscience
Title: Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice.
Volume: 97
Issue: 3
Pages: 419-24
Publication
First Author: Ophir G
Year: 2005
Journal: Neurobiol Dis
Title: Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade.
Volume: 20
Issue: 3
Pages: 709-18
Publication
First Author: Lv S
Year: 2023
Journal: Aging Cell
Title: ApoE4 exacerbates the senescence of hippocampal neurons and spatial cognitive impairment by downregulating acetyl-CoA level.
Volume: 22
Issue: 9
Pages: e13932
Publication
First Author: Matsushima Y
Year: 2001
Journal: J Atheroscler Thromb
Title: Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds.
Volume: 8
Issue: 3
Pages: 71-9
Publication    
First Author: Haghani A
Year: 2020
Journal: Elife
Title: Mouse brain transcriptome responses to inhaled nanoparticulate matter differed by sex and APOE in Nrf2-Nfkb interactions.
Volume: 9
Publication
First Author: Ezra Y
Year: 2003
Journal: Neuroscience
Title: Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury.
Volume: 121
Issue: 2
Pages: 315-25
Publication
First Author: Ferguson S
Year: 2010
Journal: Neuroscience
Title: Apolipoprotein E genotype and oxidative stress response to traumatic brain injury.
Volume: 168
Issue: 3
Pages: 811-9
Publication
First Author: Xu PT
Year: 1996
Journal: Neurobiol Dis
Title: Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice.
Volume: 3
Issue: 3
Pages: 229-45
Publication
First Author: Zhang A
Year: 2021
Journal: Commun Biol
Title: Cadmium exposure modulates the gut-liver axis in an Alzheimer's disease mouse model.
Volume: 4
Issue: 1
Pages: 1398
Publication
First Author: Ophir G
Year: 2003
Journal: Neurobiol Dis
Title: Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
Volume: 12
Issue: 1
Pages: 56-64
Publication
First Author: Levi O
Year: 2007
Journal: J Neurochem
Title: Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Volume: 103
Issue: 3
Pages: 1031-40
Publication
First Author: Levi O
Year: 2007
Journal: J Neurochem
Title: Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice.
Volume: 100
Issue: 1
Pages: 202-10
Publication
First Author: Ewing MM
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice.
Volume: 31
Issue: 1
Pages: 95-101
Publication
First Author: Comley LH
Year: 2011
Journal: Hum Mol Genet
Title: ApoE isoform-specific regulation of regeneration in the peripheral nervous system.
Volume: 20
Issue: 12
Pages: 2406-21
Publication
First Author: Levi O
Year: 2005
Journal: J Neurochem
Title: Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation.
Volume: 95
Issue: 4
Pages: 987-97
Publication
First Author: Cudaback E
Year: 2011
Journal: FASEB J
Title: Apolipoprotein E isoform-dependent microglia migration.
Volume: 25
Issue: 6
Pages: 2082-91
Publication
First Author: Tengeler AC
Year: 2020
Journal: FASEB J
Title: Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr(-/-) .Leiden mice.
Volume: 34
Issue: 7
Pages: 9575-9593
Publication  
First Author: Olga L
Year: 2021
Journal: EBioMedicine
Title: Lipid ratios representing SCD1, FADS1, and FADS2 activities as candidate biomarkers of early growth and adiposity.
Volume: 63
Pages: 103198
Publication
First Author: Bietrix F
Year: 2010
Journal: Arterioscler Thromb Vasc Biol
Title: Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Volume: 30
Issue: 5
Pages: 931-7
Publication
First Author: Morrison MC
Year: 2018
Journal: Hepatol Commun
Title: Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden Mice.
Volume: 2
Issue: 12
Pages: 1513-1532
Publication
First Author: Schoemaker MH
Year: 2017
Journal: PLoS One
Title: A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
Volume: 12
Issue: 7
Pages: e0180648
Publication
First Author: Komninos D
Year: 2022
Journal: Sci Rep
Title: High fat diet-induced obesity prolongs critical stages of the spermatogenic cycle in a Ldlr-/-.Leiden mouse model.
Volume: 12
Issue: 1
Pages: 430
Publication  
First Author: Seidel F
Year: 2023
Journal: Front Cell Neurosci
Title: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.
Volume: 17
Pages: 1205261
Publication  
First Author: Inia JA
Year: 2023
Journal: Int J Mol Sci
Title: Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice.
Volume: 24
Issue: 10
Publication  
First Author: Seidel F
Year: 2022
Journal: Int J Mol Sci
Title: Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.
Volume: 23
Issue: 18
Publication
First Author: Post SM
Year: 2006
Journal: Arterioscler Thromb Vasc Biol
Title: Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol.
Volume: 26
Issue: 12
Pages: 2724-30
Publication
First Author: Post SM
Year: 2004
Journal: Arterioscler Thromb Vasc Biol
Title: Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
Volume: 24
Issue: 4
Pages: 768-74
Publication
First Author: van Vlijmen BJ
Year: 2001
Journal: Circ Res
Title: Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.
Volume: 88
Issue: 8
Pages: 780-6
Publication
First Author: Karper JC
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice.
Volume: 31
Issue: 5
Pages: 1033-40
Publication
First Author: Hollestelle SC
Year: 2004
Journal: Circulation
Title: Toll-like receptor 4 is involved in outward arterial remodeling.
Volume: 109
Issue: 3
Pages: 393-8
Publication
First Author: de Winther MP
Year: 1999
Journal: Atherosclerosis
Title: Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice.
Volume: 144
Issue: 2
Pages: 315-21
Publication
First Author: Monraats PS
Year: 2005
Journal: FASEB J
Title: Tumor necrosis factor-alpha plays an important role in restenosis development.
Volume: 19
Issue: 14
Pages: 1998-2004
Publication
First Author: Boesten LS
Year: 2005
Journal: Cardiovasc Res
Title: Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice.
Volume: 66
Issue: 1
Pages: 179-85
Publication
First Author: van Ree JH
Year: 1995
Journal: Atherosclerosis
Title: Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding.
Volume: 112
Issue: 2
Pages: 237-43
Publication
First Author: Simonovitch S
Year: 2019
Journal: J Alzheimers Dis
Title: The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.
Volume: 70
Issue: 3
Pages: 861-875
Publication
First Author: de Jong RCM
Year: 2017
Journal: PLoS One
Title: The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development.
Volume: 12
Issue: 10
Pages: e0185820
Publication
First Author: Kim M
Year: 2023
Journal: Sci Rep
Title: Integrative analysis of hepatic transcriptional profiles reveals genetic regulation of atherosclerosis in hyperlipidemic Diversity Outbred-F1 mice.
Volume: 13
Issue: 1
Pages: 9475
Publication  
First Author: Pouwer MG
Year: 2018
Journal: Front Cardiovasc Med
Title: The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model.
Volume: 5
Pages: 55
Publication
First Author: Westerterp M
Year: 2006
Journal: Arterioscler Thromb Vasc Biol
Title: Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Volume: 26
Issue: 11
Pages: 2552-9
Publication
First Author: Boon MR
Year: 2014
Journal: FASEB J
Title: Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity.
Volume: 28
Issue: 12
Pages: 5361-75
Publication
First Author: van den Hoek AM
Year: 2021
Journal: Sci Rep
Title: Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men.
Volume: 11
Issue: 1
Pages: 5050
Publication
First Author: Tarasco E
Year: 2018
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Phenotypical heterogeneity in responder and nonresponder male ApoE*3Leiden.CETP mice.
Volume: 315
Issue: 4
Pages: G602-G617
Publication
First Author: Geerling JJ
Year: 2014
Journal: Diabetes
Title: Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice.
Volume: 63
Issue: 3
Pages: 880-91
Publication  
First Author: Liu C
Year: 2022
Journal: Atherosclerosis
Title: Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
Volume: 362
Pages: 47-55
Publication    
First Author: Kurt Z
Year: 2023
Journal: Elife
Title: Shared and distinct pathways and networks genetically linked to coronary artery disease between human and mouse.
Volume: 12
Publication
First Author: van der Hoogt CC
Year: 2007
Journal: J Lipid Res
Title: Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.
Volume: 48
Issue: 8
Pages: 1763-71
Publication
First Author: Heemskerk MM
Year: 2014
Journal: Am J Physiol Endocrinol Metab
Title: Long-term niacin treatment induces insulin resistance and adrenergic responsiveness in adipocytes by adaptive downregulation of phosphodiesterase 3B.
Volume: 306
Issue: 7
Pages: E808-13
Publication
First Author: Schuster S
Year: 2019
Journal: Sci Rep
Title: Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice.
Volume: 9
Issue: 1
Pages: 11079
Publication
First Author: van Dam AD
Year: 2015
Journal: Diabetes
Title: Salsalate activates brown adipose tissue in mice.
Volume: 64
Issue: 5
Pages: 1544-54
Publication
First Author: de Haan W
Year: 2009
Journal: Biochim Biophys Acta
Title: PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice.
Volume: 1791
Issue: 3
Pages: 191-7
Publication
First Author: Bennett BJ
Year: 2015
Journal: PLoS Genet
Title: Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.
Volume: 11
Issue: 12
Pages: e1005711
Publication
First Author: Pouwer MG
Year: 2020
Journal: J Lipid Res
Title: Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice.
Volume: 61
Issue: 3
Pages: 365-375
Publication
First Author: Zhou E
Year: 2021
Journal: Arterioscler Thromb Vasc Biol
Title: Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice.
Volume: 41
Issue: 4
Pages: 1474-1486
Publication
First Author: Rios-Morales M
Year: 2022
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Butyrate oxidation attenuates the butyrate-induced improvement of insulin sensitivity in myotubes.
Volume: 1868
Issue: 11
Pages: 166476
Publication
First Author: van der Hoorn JW
Year: 2008
Journal: Arterioscler Thromb Vasc Biol
Title: Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
Volume: 28
Issue: 11
Pages: 2016-22
Publication
First Author: Wang Y
Year: 2011
Journal: J Lipid Res
Title: CETP expression reverses the reconstituted HDL-induced increase in VLDL.
Volume: 52
Issue: 8
Pages: 1533-41
Publication
First Author: de Haan W
Year: 2008
Journal: Atherosclerosis
Title: Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
Volume: 197
Issue: 1
Pages: 57-63
Publication  
First Author: Wang F
Year: 2022
Journal: Int J Mol Sci
Title: Oxy210, a Semi-Synthetic Oxysterol, Exerts Anti-Inflammatory Effects in Macrophages via Inhibition of Toll-like Receptor (TLR) 4 and TLR2 Signaling and Modulation of Macrophage Polarization.
Volume: 23
Issue: 10
Publication
First Author: Auvinen HE
Year: 2013
Journal: PLoS One
Title: Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.
Volume: 8
Issue: 5
Pages: e63882
Publication  
First Author: Paalvast Y
Year: 2017
Journal: Physiol Rep
Title: Male apoE*3-Leiden.CETP mice on high-fat high-cholesterol diet exhibit a biphasic dyslipidemic response, mimicking the changes in plasma lipids observed through life in men.
Volume: 5
Issue: 19
Publication
First Author: Karper JC
Year: 2013
Journal: PLoS One
Title: TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.
Volume: 8
Issue: 7
Pages: e67923
Publication
First Author: Trion A
Year: 2005
Journal: Arterioscler Thromb Vasc Biol
Title: No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
Volume: 25
Issue: 8
Pages: 1635-40
Publication  
First Author: Pouwer MG
Year: 2019
Journal: J Diabetes Res
Title: The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis.
Volume: 2019
Pages: 9727952
Publication
First Author: Morrison M
Year: 2014
Journal: Atherosclerosis
Title: Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo.
Volume: 233
Issue: 1
Pages: 149-56
Publication
First Author: Koopmans SJ
Year: 2001
Journal: Diabetologia
Title: Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
Volume: 44
Issue: 4
Pages: 437-43
Publication
First Author: Bovenschen N
Year: 2005
Journal: Blood
Title: LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo.
Volume: 106
Issue: 3
Pages: 906-12
Publication
First Author: Vaessen SF
Year: 2009
Journal: J Lipid Res
Title: Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.
Volume: 50
Issue: 5
Pages: 880-4
Publication
First Author: Ason B
Year: 2014
Journal: J Lipid Res
Title: PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
Volume: 55
Issue: 11
Pages: 2370-9
Publication  
First Author: Berbée JF
Year: 2015
Journal: Nat Commun
Title: Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.
Volume: 6
Pages: 6356
Publication
First Author: Levi O
Year: 2003
Journal: Neurobiol Dis
Title: ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory.
Volume: 13
Issue: 3
Pages: 273-82
Publication
First Author: van Olffen RW
Year: 2010
Journal: J Innate Immun
Title: CD70-driven chronic immune activation is protective against atherosclerosis.
Volume: 2
Issue: 4
Pages: 344-52
Publication
First Author: Calkin AC
Year: 2014
Journal: Circ Res
Title: Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.
Volume: 115
Issue: 4
Pages: 442-9
Publication
First Author: Kim JB
Year: 2012
Journal: Circulation
Title: Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice.
Volume: 126
Issue: 15
Pages: 1896-906
Publication
First Author: Kliffen M
Year: 2000
Journal: Br J Ophthalmol
Title: The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.
Volume: 84
Issue: 12
Pages: 1415-9
Publication
First Author: Lutgens E
Year: 2001
Journal: Arterioscler Thromb Vasc Biol
Title: Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice.
Volume: 21
Issue: 8
Pages: 1359-65
Publication
First Author: Mulder M
Year: 2001
Journal: Lab Invest
Title: Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging.
Volume: 81
Issue: 7
Pages: 953-60
Publication
First Author: van den Berg R
Year: 2018
Journal: Cell Rep
Title: A Diurnal Rhythm in Brown Adipose Tissue Causes Rapid Clearance and Combustion of Plasma Lipids at Wakening.
Volume: 22
Issue: 13
Pages: 3521-3533
Publication  
First Author: Zhao L
Year: 2016
Journal: Neurobiol Aging
Title: Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models.
Volume: 44
Pages: 159-172
Publication  
First Author: Bartelt A
Year: 2017
Journal: Nat Commun
Title: Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport.
Volume: 8
Pages: 15010
Publication  
First Author: Kroon J
Year: 2021
Journal: Mol Metab
Title: A physiological glucocorticoid rhythm is an important regulator of brown adipose tissue function.
Volume: 47
Pages: 101179
Publication
First Author: Jin H
Year: 2009
Journal: J Invest Dermatol
Title: Animal models of atopic dermatitis.
Volume: 129
Issue: 1
Pages: 31-40
Publication      
First Author: Fedoseienko A
Year: 2018
Journal: Circ Res
Title: COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking.